Biotech CEO on RNAI and Medicine of the Future

from At Barron's · host At Barron's

Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Dec 19, 2024

Embed this episode

Attribution link and audio player

What this episode covers

Alnylam Pharmaceuticals CEO Yvonne Greenstreet discusses why RNAI can be used to treat an array of diseases, the company's medicines using this technology, and more.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Biotech CEO on RNAI and Medicine of the Future

0:00 21:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of At Barron's?

This episode is 21 minutes long.

When was this At Barron's episode published?

This episode was published on December 19, 2024.

Can I download this At Barron's episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!